This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Has IBM Finally Gotten Cheap?

Revenue, with which the company has long struggled, fell again by 3% -- missing analysts' estimates for the second consecutive quarter. If you believe that I'm being too hard on this company, understand that this quarter's 3% revenue drop preceded 4% decline in the April quarter, which then preceded a 2% drop in the January quarter.

I'm sure by now you get the picture.

I believe that if this was any other company not named IBM, say, BlackBerry (BBRY) or Microsoft (MSFT - Get Report), there would have been a deluge of articles proclaiming the company's death.

But not IBM. And when looking at the results on a segmental basis, there are even more reasons for concern. First, I don't like the fact that the company's usually strong service business was down 4% year over year.

Service revenue has been IBM's "offsetting strength" -- supporting the company's perpetually weak hardware business, which was down again this quarter -- this time by 12%. It's time that investors face a new reality -- this company is no longer untouchable. It's going to be hard for IBM to maintain any sort of competitive advantage over Oracle (ORCL) and Accenture (ACN).
[Read: <a target="blank" data-add-tracking="true" href=""><em>Is Pepsi Better Than Coke?</em></a>]

There aren't enough data to suggest that IBM is losing share to either company. But I can tell you that neither has enjoyed the benefit of the doubt that has IBM. And nor do their stock prices presume perfect execution.

Along those lines, the fact that IBM posted a margin decline of close to 2.5%, which led to a 15% decline in operating income, suggest that IBM is seeing some pricing pressure -- likely from Oracle and

These earnings results, as lackluster as they were, didn't vary too much from IBM's first-quarter outcome, upon which I recommended selling the stock. Shares were trading at around $205 at the time. Today, investors have begun to pay a little more attention.

While, I don't believe that this quarter or even the next will be enough to define IBM's long-term outlook, it does, however, force a sort of reevaluation about how this company is judged. Even with its strong balance sheet, which included $10 billion in cash, I don't think I can force myself to buy this stock -- at least not until revenue growth returns. But should the stock fall another 5%, say, to $180, at that point I'll reconsider.

At the time of publication, the author was long AAPL.

This article was written by an independent contributor, separate from TheStreet's regular news coverage.
Richard Saintvilus is a co-founder of where he serves as CEO and editor-in-chief. After 20 years in the IT industry, including 5 years as a high school computer teacher, Saintvilus decided his second act would be as a stock analyst - bringing logic from an investor's point of view. His goal is to remove the complicated aspect of investing and present it to readers in a way that makes sense.

His background in engineering has provided him with strong analytical skills. That, along with 15 years of trading and investing, has given him the tools needed to assess equities and appraise value. Richard is a Warren Buffett disciple who bases investment decisions on the quality of a company's management, growth aspects, return on equity, and price-to-earnings ratio.

His work has been featured on CNBC, Yahoo! Finance, MSN Money, Forbes, Motley Fool and numerous other outlets.

2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
IBM $145.58 -1.00%
MSFT $49.81 -0.18%
AAPL $93.05 -1.90%
FB $116.52 -0.18%
GOOG $689.78 -0.18%


Chart of I:DJI
DOW 17,695.50 -135.26 -0.76%
S&P 500 2,054.52 -21.29 -1.03%
NASDAQ 4,752.9240 -52.3670 -1.09%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs